194 reports of this reaction
4.2% of all PHENYLEPHRINE HCL reports
#4 most reported adverse reaction
ANXIETY is the #4 most commonly reported adverse reaction for PHENYLEPHRINE HCL, manufactured by Strategic Sourcing Services LLC. There are 194 FDA adverse event reports linking PHENYLEPHRINE HCL to ANXIETY. This represents approximately 4.2% of all 4,600 adverse event reports for this drug.
Patients taking PHENYLEPHRINE HCL who experience anxiety should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ANXIETY is moderately reported among PHENYLEPHRINE HCL users, representing a notable but not dominant share of adverse events.
In addition to anxiety, the following adverse reactions have been reported for PHENYLEPHRINE HCL:
The following drugs have also been linked to anxiety in FDA adverse event reports:
ANXIETY has been reported as an adverse event in 194 FDA reports for PHENYLEPHRINE HCL. This does not prove causation, but indicates an association observed in post-market surveillance data.
ANXIETY accounts for approximately 4.2% of all adverse event reports for PHENYLEPHRINE HCL, making it a notable side effect.
If you experience anxiety while taking PHENYLEPHRINE HCL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.